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Hypothyroidism is associated with an increased risk for cardiovascular disease, which can not be fully explained by the
atherogenic lipid profile, particularly total cholesterol and LDL-C, and other pathogenic factors may be involved. Plasma
total homocysteine (tHcy) is an independent risk factor for cardiovascular disease and accelerated atherosclerosis. The
aim of this study was to investigate the serum total homocysteine (tHcy) levels and its relation to total cholesterol,
creatinine and thyroid hormones fT3, fT4 and TSH levels in overt hypothyroid patients compared to control subjects. In
this study thirty recently diagnosed, non-treated overt hypothyroid patients (f=27, m=3) and twenty normal volunteers
control (f=18, m=2) were included and subjected to determination of serum tHcy by enzyme immunoassay (EIA)
technique, fT3, fT4 and TSH by Elecsys cobas e 601 analyzer, total cholesterol by enzymatic method and creatinine by
kinetic method. The data was statistically analysed by SPSS-10 and p values less than 0.05 were considered significant.
Our results showed that there were a significant increase of tHcy, TSH, T.cholesterol and creatinine levels by 113%, 12-
folds, 58% and 54%, respectively, and a significant decrease of fT4 and fT3 levels by 49.6% and 56.4% , respectively, in
hypothyroid patients than in control group. For tHcy (Mean±SD, 24.45±5.50 μmol/l vs 11.48±3.03 μmol/l, respectively; P
< 0.001). tHcy was significantly positively correlated with TSH, creatinine and age and negatively correlated with free
thyroxine (fT4) and no significant correlations with fT3 and T.cholesterol. In conclusion, our study confirmed the
observation of elevated serum tHcy, T.cholesterol and creatinine in overt hypothyroidism and the presence of an
inverse relation between tHcy with fT4 and a positive relation with TSH.
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Hypothyroidism is associated with an increased risk for
atherosclerotic cardiovascular disease (Ichiki, 2010) and
cardiovascular morbidity (Hak et al., 2000) , which is
in accordance with autopsy studies showing that the
atherosclerotic process is increased in hypothyroidism
(Steinberg, 1968) and decreased in hyperthyroidism
(Myasnikov et al., 1963). The increased cardiovascular
morbidity in hypothyroid patients has been related to
elevated levels of cholesterol and low-density lipoprotein* Correspondence: sshrmany@yahoo.co.uk
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reproduction in any medium, provided the origcholesterol (LDL-C), which are normalized after thyoid
hormones replacement (Yazbeck et al., 2001). Elevated
cholesterol and lipoprotein levels may be partly respon-
sible for the high risk of vascular disease associated with
hypothyroidism. However, lipid abnormalities in hypo-
thyroid patients do not fully account for the accelerated
atherosclerosis and cardiovascular disease, and other
pathogenic factors may be involved (Masaki et al., 1992;
Mamiya et al., 1989).
Total homocysteine (tHcy) in plasma is an independent
risk factor for cardiovascular disease (Saeed et al., 2006;
Virdis et al., 2002). It has often been shown to be related to
occlusive vascular disease independently of other known
risk factors (den Heijer et al., 2005). Hyperhomocysteinemia
induces endothelial injury, oxidative stress, smooth muscle
hypertrophy and oxidation of LDL-cholesterol. Platelethis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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vasomotor function are altered in the presence of high
plasma levels of Hcy (Medina et al., 2001). The plasma
level of tHcy is affected by several genetic and acquired
factors and is elevated under conditions of vitamin folate
and cobalamin deficiencies and in renal failure (de Bree
et al., 2001; Schneede et al., 2000). In the present study we
investigated the serum total homocysteine (tHcy) levels
and its relation to T.cholesterol, creatinine and thyroid
hormones fT3, fT4 and TSH levels in recently diagnosed
overt hypothyroid patients compared to control subjects.
Material and methods
Subjects
This study was conducted in Sana’a, Yemen, from April to
May, 2013. It included 50 subjects aged 20 to 55 years.
The patient’s group consisted of 30 newly diagnosed,
non-treated overt hypothyroid patients (27 females
and 3 males) (mean age ±SD, 37.43±6.92; median, 37.0;
ranged from 28 to 55; 95% CI, 34.8-40.0 years old) Patients
with any heart diseases, renal diseases and bone diseases
and treated patients have been excluded. These patients
were selected randomly each day from subjects referred
to the out-patient’s clinics of endocrinology and general
surgery departments (n=10) of Kuwait University Hospital
(KUH) and from subjects referred to the specialized
medical laboratories, Al-Aulaqi (n=12) and The Med-Lab.
(n=8), for ELISA thyroid hormones measurements, the
diagnosis of overt hypothyroidism was based on low levels
of serum fT4 and/or fT3 and high TSH levels. The control
group included 20 subjects (f=18; m=2) (mean age ±SD,
29.75±6.15; median, 29; ranged from 20–45; 95% CI,
26.9-32.6 years old) as normal non-hypothyroid volunteers
from the workers and students of KUH. All participants
gave their informed consent to participate in this study.
Sample collection
Non-fasting blood samples (5ml) of venous blood were
collected randomly from each of patients and controls.
Sample of plain tube was left to clot for 30 minutes then
centrifuged at 3500 × g for 5 minutes; the separated serum
was divided into several aliquots and stored at −70°C until
analysis and estimation of fT3, fT4 and TSH. The
remaining serum samples were stored at – 70°C for later
analysis for the estimation of total homocysteine, total
cholesterol and creatinine levels.
Biochemical methods
Determination of total homocysteine (tHcy)
Serum tHcy concentrations were determined by a commer-
cially available Axis® Homocysteine enzyme immunoassay
(EIA) reagent kit supplied by (Axis-Shield, Axis Biochemi-
cals ASA, Distributed by IBL, Hamburg, Germany) and run
on Multiscan EX from Labsystem, Finland. The referencevalues for adult male and females between 5 and 15 μmol/L
and among alderly (>60 years) was 5–20 μmol/L.Determination of thyroid hormones
Serum fT3, fT4 and TSH concentrations were determined
by electrochemiluminescence immunoassay (ECLIA) tech-
nique intended for use on the Elecsys reagent kits supplied
by Roche Diagnostics GmbH (Mannheim, Germany) and
run on cobas e 601 immunoassay analyzer from Roche
Diagnostics Ltd, Switzerland. The reference range for
serum fT3 (2.0-4.4 pg/mL), fT4 (0.93-1.7 ng/dL) and TSH
(0.27-4.20 mIU/mL).Determination of total cholesterol and creatinine
Serum total cholesterol and creatinine concentrations were
estimated using kits supplied by Randox Lab. Ltd. (United
Kingdom) and run on RA-50 Chemistry Analyser from
Bayer, Ireland. The reference range for serum total choles-
terol (up to 5.18 mmol/L), creatinine (female; 44.2-79.5
μmol/L, male: 53.0-97.2 μmol/L).Statistical analyses
All statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS software version
10.0 for Windows, Inc., Chicago, Illions, USA) to indicate
the degree of significant between the mean values of the
patient groups and the mean values of the corresponding
controls. Descriptive data were given as mean ± standard
deviation (SD). All tests were two-tailed and p values less
than 0.05 were considered statistically significant. Pearson
correlation coefficients (r) were calculated to quantify the
relationship between folate and other variables.Results
Total homocysteine (tHcy)
Total homocysteine (tHcy), there was a significant increase
mean tHcy in hypothyroid patients than in control group
by13.0 μmol/l (113%) (Mean ± SD, 24.45±5.50 μmol/l; 95%
confidence interval (CI), 22.40-26.51 vs 11.48±3.03 μmol/l;
95% CI, 10.06-12.90, respectively; p=0.001) (Table 1). The
median tHcy of hypothyroid patients was 13.5 μmol/l
higher than that of control subjects. In hypothyroid pa-
tients, tHcy was ranged from 12.60 to 32.90 as compared
to control 6.00 to 18.00 μmol/l. 25 of 30 (83%) hypothyroid
patients had tHcy levels >18.0 μmol/L, the upper limit of
the control. (Table 2) showed that there were a significant
positively correlation in hypothyroid patients between tHcy
with TSH levels (p=0.001), creatinine (p < 0.001), and age
(p=0.001). In contrast, tHcy was significantly negatively cor-
related with fT4 (r= −0.535; p=0.002), and non-significantly
correlated with fT3 and T.cholesterol (Figures 1, 2 and 3).
Table 1 Comparison between serum levels of tHcy, FT3, FT4, TSH, T.cholesterol and creatinine in hypothyroid patients
and control subjects
Groups Hypothyroid Control P value
Variables patients (n=30) subjects (n=20)
(Mean ± SD) (Mean ± SD)
Total homocysteine (tHcy) (μmol/L) 24.45 ± 5.50 11.48 ± 3.03 0.001
Free triiodothyronine (FT3) (pg/ml) 1.46 ± 1.20 3.35 ± 0.62 0.001
Free thyroxine (FT4) (ng/dL) 0.69 ± 0.32 1.37 ± 0.22 0.001
Thyroid-stimulating hormone (TSH) (mlU/mL) 26.69 ± 8.05 2.03 ± 1.09 0.001
Total cholesterol (mmol/L) 6.29 ± 1.56 3.98 ± 0.57 0.001
Creatinine (μmol/L) 98.75 ± 27.07 64.04 ± 9.53 0.001
Age (Year) 37.43 ± 6.92 29.75 ± 6.15 0.001
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Serum TSH levels in all 30 (100%) hypothyroid patients
were significantly higher than the control group by 12.0-
folds (Mean±SD, 26.69±8.05 mIU/mL; median, 26.75;
ranged from 11.80 to 42.50 vs 2.03±1.09 mIU/mL, median,
2.0; ranged from 0.45 to 4.0, respectively; p=0.001) (Table 1).
Serum TSH level was significantly positively correlated
with tHcy (r= 0.582; p=0.001) and creatinine (r= 0.482;
p=0.007) and negatively correlated with fT4 (r= −0.456;
p=0.011) and non-significantly correlated with total chol-
esterol, fT3 and age. On the other hand, both fT4 and fT3
were observed to be significantly lower in the hypothyroid
patients by 49.6% and 56.4%, respectively, compared with
the control group (Table 1). For fT4, the mean±SD was
0.69±0.32 ng/dl; median was 0.70; and ranged from 0.15
to 1.60 vs 1.29±0.18 ng/dl, median, 1.35; ranged from
0.97 to 1.80, respectively; p=0.001). Serum fT4 level was
significantly negatively correlated with TSH (r= −0.456;
p=0.011), tHcy (r= −0.535; p=0.002) and creatinine
(r= −0.436; p=0.016) and non-significantly correlated with
other variables. For fT3, the mean±SD was 1.46±1.20
pg/ml; median was 0.82; and ranged from 0.25 to 3.83
vs 3.35±0.62 pg/ml, median, 3.45; ranged from 2.20 to
4.20, respectively; p=0.001). Serum fT3 level was non-
significantly correlated with other variables. 25 of 30Table 2 Correlations between serum tHcy and other
variables in hypothyroid patients
Variable Hypothyroidism (n=30)
r P†






†Pearson correlation, Correlation is significant at the 0.05 level (2-tailed).(83%) hypothyroid patients had fT4 levels < 0.93 ng/dl,
the lower limit of assay, whereas 20 of 30 (67%) had
fT3 levels < 2.0 pg/ml, the lower limit of assay.
T.cholesterol and creatinine
Both serum total cholesterol and creatinine levels were
significantly higher by 58% and 54%, respectively, com-
pared with the control group (Table 1). For T.cholesterol,
the mean±SD was 6.29±1.56 mmol/l; median was 5.97;
ranged from 4.20 to 9.90 vs 3.98±0.57 mmol/l; median,
4.18; ranged from 2.80 to 4.80, respectively; p=0.001). For
creatinine, the mean±SD was 98.75±27.07 μmol/l; median
was 97.0; ranged from 48.0 to 138.5 μmol/l vs 64.0±9.53
μmol/l; median, 65.7; ranged from 45.0 to 77.0, respect-
ively; p=0.001). 23 of 30 (77%) of hypothyroid patients
were hypercholesterolemic (>5.18 mmol/l, the upper limit
of assay), and 20 of 25 (80%) of hyperhomocysteinemic
hypothyroid patients were hypercholesterolemic, whereas
21 of 30 (70%) of hypothyroid patients had elevated serum
creatinine levels than the upper limit of assay.
Discussion
In the present study, elevated serum total homocysteine
(tHcy) was found to be strongly associated with hypo-
thyroidism. As shown in (Table 1), serum levels of tHcy
were significantly higher in patients with hypothyroidism
by 113% compared with the control group (p < 0.001).
This observation is in line with other previous studies
(Gunduz et al., 2012; Ozmen et al., 2006; Diekman et al.,
2001; Lien et al., 2000) and was not in agreement with
Orzechowska et al. (2007). They observed that tHcy
levels were non-significantly higher in patients with hypo-
thyroidism than in healthy subjects. In our study, tHcy
was significantly related to TSH, creatinine and age and
negatively related to fT4 and no relations with fT3 and
cholesterol. Similar observations have been made in some
but not all studies (Orzechowska et al., 2007; Lien et al.,
2000; Nedrebo et al., 1998). The increase observed in tHcy










Figure 1 The relationship between tHcy (var5) and TSH (var4): There was a positive relation.
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an increase in plasma Hcy level of 4 μmol/l, confers a
40% increase in relative risk for coronary heart disease
compared with healthy controls (Boushey et al., 1995).
Increased tHcy levels might be the result of two mecha-
nisms either increased tHcy formation or decreased renal
tHcy clearance due to direct effect of thyroid hormones
on the tHcy metabolism in the liver and clearance in the
kidney (Orzechowska et al., 2005). The former may be
explained as thyroid hormone deficiency decreases hepatic







Figure 2 Curve estimation between tHcy (var5) and creatinine (var7):tHcy to methionine, methylenetetrahydrofolate reductase
(MTHFR). Experimental studies have also indicated that
MTHFR was decreased in hypothyroidism and increased in
hyperthyroidism (Selhub, 1999). The later mechanism may
be explained as decreased renal tHcy metabolism leads to
low renal tHcy, which, in turn, leads to decreased glom-
erular filtration rate (GFR) and increased serum creatinine
(Hollander et al., 2005; Nakahama et al., 2001).
On the other hand, In line with previous studies, we
found that serum creatinine was significantly (p < 0.001)
higher in hypothyroid patients by 54% compared to the14012000
Observed
Linear










Figure 3 Curve estimation between tHcy (var5) and fT4 (var3): There was an inverse relation.
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relation between tHcy and serum creatinine levels in
hypothyroid patients. These observations are consistent
with other studies (Diekman et al., 2001; Nakahama et al.,
2001; Lien et al., 2000). Serum creatinine levels were
reported to decrease in hyperthyroidism and increase in
hypothyroidism, and elevated levels can be reduced by
thyroid hormone replacement (Diekman et al., 2001). The
moderate increase of creatinine might be explained by
direct effect of thyroid hormones on renal function and/or
tHcy metabolism and clearance in kidney (Hollander et al.,
2005; Nakahama et al., 2001). The former may be explained
by the hypodynamic circulation in hypothyroidism (Polikar
et al., 1993). Thyroid hormones are cardiotonic agents,
which increase cardiac output while lowering systemic
vascular resistance (Klemperer et al., 1995), resulting in
increased renal blood flow (Polikar et al., 1993). This, in
turn, may increase the glomerular filtration rate (GFR),
which is related to serum creatinine (Montenegro et al.,
1996), but also closely associated with plasma tHcy
(Bostom et al., 1999). The later may be explained as a
result of impaired renal tHcy clearance, possibly due to
impaired renal tHcy metabolism (Guttormsen et al., 1997).
Thus, thyroid hormones may influence the tHcy serum
levels both through effects on Hcy formation and its
elimination from plasma.
We observed that serum mean total cholesterol levels
were significantly higher in patients with hypothyroidism
by 58% compared to control group (p < 0.001). These
results were consistent with (Gunduz et al., 2012; Yazbeck
et al., 2001; Lien et al., 2000). Hypercholesterolemia wasseen in 77% of hypothyroid patients, and in 80% of
hyperhomocysteinemic hypothyroid patients. Increased
serum cholesterol might be attributed to the influence
of thyroid hormones on the cholesterol metabolism or
disposition (Ness and Lopez, 1995), and this may contribute
to the association between hypothyroidism and hyperchol-
esterolemia or it might be attributed to the effects of Hcy
on cholesterol production and secretion, since tHcy
stimulate the production and secretion of cholesterol in
hepatic cells (Karmin et al., 1998) and this may contribute
to the association between cholesterol and homocysteine
observed in the present study as in some epidemiological
studies (Arnesen et al., 1995, Nygard et al., 1995). Since
hypercholesterolemia may partly be responsible for in-
creased cardiovascular morbidity, but can not fully explain
the accelerated atherosclerosis, the increase in both serum
tHcy and cholesterol may confer increased cardiovascular
risk observed in these hypothyroid patients.
Conclusion
In conclusion, our study confirmed the observation of
elevated serum tHcy, T.cholesterol and creatinine in
overt hypothyroidism and the presence of an inverse
relation between tHcy with fT4 and a positive relation
with TSH. Increased tHcy levels may contribute to a
greater cardiovascular risk. Hyperhomocysteinemia,
together with hypercholesterolemia, may explain the
accelerated atherosclerosis in these patients and we
recommended tHcy screening of hypothyroid patients, as
an independent risk factor for accelerated atherosclerosis
and cardiovascular disease.
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